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Idiopathic acquired cold-induced urticaria has pro-
vided a model to study release of mast cell-derived chem-
ical mediators into the blood and alterations of neutro-
philic leukocyte motility. A factor chemotactic for neu-
trophilic leukocytes appeared in the circulation after 
local experimental challenge with ice. After partial pu-
rification by Sephadex G-200 gel filtration and by anion 
and cation exchange chromatography the neutrophil 
chemotactic activity was excluded on Sepharose 4B gel 
filtration, indicating a molecular weight in excess of 
750,000. On isoelectric focusing it exhibited a neutral 
isoelectric point. This chemotactic factor showed pref-
erential chemotactic activity for neutrophils and deac-
tivated these cells in vitro and in vivo. HMW-NCF may 
prove to be a useful marker of mast cell activation and 
its release may modulate the capacity for motility of 
neutrophilic leukocytes in humans. 
Patients with the disorder of acquired cold-induced urticaria/ 
angioedema have provided an experimental model for the study 
of mast cell mediator release and of leukocyte motility [1, 2]. 
Evidence for involvement of the mast cell in this disorder is 
derived from the ability of patients' serum or lgE to transfer 
cold urticaria to the skin of a normal person [3] as well as from 
finding histamine and a low molecular weight eosinophil che-
motactic factor, comparable in size to the eosinophil chemotac-
tic factor of anaphylaxis (ECF-A), in the venous blood after 
local challenge with ice [ 4-6]. Augmented neutrophil chemo-
tactic activity has been recognized in the venous blood of such 
patients after local ice challenge [1]. This neutrophil chemotac-
tic activity has a high molecular weight, a neutral isoelectric 
point, and the ability to alter the motility of neutrophilic 
polymorphonuclear leukocytes; it has been designated high 
molecular weight neutrophil chemotactic factor (HMW-N CF). 
EXPERIMENTAL PROTOCOL 
Patients with idiopathic acquired cold-induced urticaria, after giving 
informed consent, pruticipated in a protocol in which one arm was 
immersed in ice water while the control arm remained at room tem-
perature. Indwelling intravenous needles were placed in both arms at 
the antecubital fossae, and blood was obtained from both just before 
and at timed intervals after immersion of one arm. Serum was assessed 
for neutrophil chemotactic activities in a modified Boyden chamber 
assay (7]. Peripheral blood neutrophilic leukocytes were obtained for 
analysis of their motility. 
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RECOGNITION AND PARTIAL PURIFICATION OF 
HMW-NCF 
A factor chemotactic for neutrophilic polymorphonucleru· 
leukocytes increased in amount in the venous effluent of the 
cold-immersed arm in each of 7 patients with idiopathic ac-
quired cold-induced urticaria. The neutrophil chemotactic ac-
tivity was noted by 30 seconds, reached peak levels at 2 min, 
and was dissipated by 15 min (Fig 1). Normal individuals 
subjected to cold immersion did not develop augmented che-
motactic activity in the venous effluent of the challenged arm. 
Assessment of the complement system, in terms of C1, C4, C2, 
C3, and C9 functional activity and Clq, C4, C3, C5, factor B, 
properdin, and CI inhibitor protein concentrations, showed no 
differences between the normal and challenged arms; there 
were no alterations from the baseline values. 
The augmented neutrophil chemotactic activity was partially 
purified by sequential chromatographic procedures. Sephadex 
G-200 gel filtration of paired serum specimens with peak che-
motactic activity from the lesional and control arms showed 
augmented neutrophil chemotactic activity in the lesional se-
rum that filtered in the void volume. This activity was further 
purified by QAE-Sephadex chromatography, eluting between 6 
and 12 mS, and by SP-Sephadex chromatography, where it 
appeared in the effluent. The chemotactic activity was excluded 
on Sepharose 4B chromatography, indicating a molecular 
weight in excess of 750,000. On isoelectric focusing the partially 
purified neutrophil chemotactic factor exhibited a neutral iso-
electric point when focused in 2 different support media with 
single peaks of focus between pH 6.7 and 7.4 (Fig 2). 
HMW-NCF AND THE MOTILITY OF NEUTROPHILIC 
LEUKOCYTES IN VITRO 
The effect of this factor on the motility of neutrophilic 
leukocytes was studied in vitro and compared with the re-
sponses of mononuclear leukocytes. The partially pmified high 
molecular weight factor attracted neutrophilic leukocytes in a 
dose-response fashion at concentrations that had little or no 
effect on mononuclear leukocytes (Fig 3). The neutrophil re-
sponse was abrogated if the concentration gradient was abol-
ished by placing identical concentrations of the factor on the 
cell and stimulus sides, indicating that the active principle was 
a chemotactic factor. 
In addition to attracting target cells, chemotactic factors 
render these cells unresponsive to subsequent chemotactic re-
sponses, an action termed deactivation. HMW-NCF deacti-
vated neutrophils in a time- and dose-related fashion; the 
concentrations effective in deactivation were subthreshold to 
minimal compared to the chemotactic stimulus (Fig 4). 
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NEUTROPHILIC LEUKOCYTE FUNCTION IN VIVO 
Since chemotactic principles were released into the circula-
tion, the nature of the local lesional tissue alterations was 
examined. Skin biopsy specimens of the experimental angioe-
dematous lesions obtained over 24 hr showed early mast cell 
degranulation with venular endothelial cell alterations but no 
May 1980 
infiltrating polymorphonuclear leukocytes of any class [8]. The 
absence of infiltrating cells in the angioedematous lesion after 
a single challenge is due presumably to an action of the large 
amounts of released chemical mediators on the motility of the 
cells. 
The migration of neutrophilic leukocytes obtained from sub-
jects prior to and at time intervals after ice challenge and 
subsequent exposure to mediators in vivo was assessed in vitro. 
Neutrophilic leukocytes harvested from the challenged arm at 
5 min were markedly impaired in their chemotactic responses 
to HMW-NCF (Fig 5) . The neutrophil defect in the cells from 
the challenged arm was attributed to mast cell activation and 
the release of mast cell mediators in the angioedematous skin 
since neither chemical mediators nor chemotactic deactivation 
of circulating cells was found in the unchallenged arm at the 
same time. The local release of mediators also had a systemic 
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FIG l. Time-cou1·se of appearance of neut rophil chemotactic ac tivity 
in the venous efflu ent sera from 7 subjects after experimental ice 
challenge. Each point represents the mean (± 1 SD) net percent change 
in the neutrophil chemotactic activity in lesional (e) and control (0 ) 
al"ms, as compared to time zero. From reference 1. 
FIG 2. Isoelectric focusing in sucrose (upper) and in thin-layer Seph-
adex G-75 (lower) of pru·tially purified HMW-NCF. From reference 1. 
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FIG 3. Chemotactic responses of neutrophilic leukocytes (stippled 
bars) and mononucleru· leukocytes (solid bars) to the purified HMW-
NCF. The effect of eliminating the gradient by placing chemotactic 
factor in both compru·tments of the chamber is depicted by hatched 
bars. From reference 1. 
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FIG 4. Time-dependent deactivation of neutrophilic leukocytes by 
5 (0 ) or 25 (e) J.!l o_f HMW-NCF as assessed by their subsequent 
chemotactic response to 100 J.!l of the same stimulus. From reference l. 
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FIG 5. Mean percentage chemotactic response of neut rophilic leu-
kocytes as compared to response of cells obta ined prior to cold chal-
lenge. Control ru·m at 5 min (0 ) and 60 min (6); cold-challenged arm at 
5 min (e) , 60 min (&), and 4 hr (+). Vertical bars show range. The 
stimulus was HMW-N CF. From reference 2. 
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effect on neutrophils, as demonstrated by the impaired che-
motactic function of cells from both challenged and unchal-
lenged arms at 60 min. A systemic effect on neutrophil function 
is presumably due to the circulation of the neutrophilic leuko-
cytes through the cold-challenged arm and their subsequent 
dispersion throughout the circulation. The chemotactic abnor-
mality was no longer present at 4 hr. Deactivation would 
account satisfactorily for the rapid onset of the neutrophil 
defect in the cold-challenged arm, its later systemic distribution, 
and the absence of cells in the angioedematous tissue lesion. 
DISCUSSION 
A neutrophil chemotactic activity (HMW-NCF) was recog-
nized in sera of patients with idiopathic cold-induced urticaria 
after local experimental cold challenge with ice. The time-
course of the appearance of this serum chemotactic activity was 
indistinguishable from that of histamine and a low-molecular 
weight eosinophil chemotactic factor, implying a mast cell 
origin for this mediator. Chemotactic activity preferential for 
neutrophilic leukocytes and greater than 30,000 molecular 
weight has previously been noted in extracts of human leukemic 
basophils [9] and lung fragments [10], but these activities have 
not been further characterized. The appearance of augmented 
neutrophil chemotactic activity in the serum of asthmatic pa-
tients after inhalation challenge with specific antigen has also 
been reported [11, 12]. In studies of mediator release into the 
circulation ih patients with the IgE-mast cell-mediated disor-
ders cholinergic urticaria [13] and solar urticaria [14], a neutro-
phil chemotactic factor has been detected. Taken together, the 
studies in both physical urticarias and asthmatic patients [11, 
12, 15] suggest that neutrophil chemotactic activity may be a 
marker for mast cell activation in vivo. 
The observation that neutrophils are rendered less responsive 
to chemotactic stimuli in vitro, after exposure to a chemotactic 
stimulus in vivo, suggests that deactivation could be a regula-
tory mechanism for limiting the local tissue influx of inflam-
matory cells. It could also diminish general host responsiveness 
if the release of chemotactic factors was persistent or excessive. 
This work was done in collaboration with Drs. David M. Center, 
M .D., Stephen I. Wasserman, M.D., and K. Frank Austen, M.D. 
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DISCUSSION 
TIGELAAR: Is the deactivation of neutrophil chemaotaxis that you 
have described specific, in the sense that pre-exposure to HMW-NCF 
leads to unresponsiveness only to HMW-NCF and not to, for example, 
C5a? 
Soter: We have examined one other chemotactic factor, the tryptic 
digest of C5, on these cells exposed to high molecular weight NCF in 
vivo. The cells exhibit the deactivation phenomenon, so there is a 
crossdeactivation. 
BERGSTRESSER: Since this high molecular weight chemotactic factor 
found in these patients is released in the absence of a neutrophilic 
infiltrate, what do you believe the functional role of the factor to be? 
SoTER: I think it's the experimental circumstance that would deter-
mine the functional role. It is conceivable that in some inflammatory 
conditions in which the mast cell is involved, this factor could allow 
cells to enter the tissues. In this case there is a sudden massive release 
that is overwhelming the cells in the circulation preventing their entry 
into tissue sites. 
KATZ: ln that regard, have you mJected 1U 
SOTER: No. 
RAY: .Will NCF-induce lysosomal enzyme release of beta-glucoroni-
dase or leucine amino peptidase activity as noted with other chemoat-
tractants? 
SoTER: We do not find that it is a model of other classes of chemo-
tactic factors. For example, the chemotactic factors derived from the 
arachidonic pathway do not release lysosomal enzymes. Similar obser-
vations were noted with the tetrapeptide ECF-A. 
GIGLI: Do you think that the size of this factor would indicate that 
it may be a complex of 2 proteins? 
SoTER: This is a possibility but it is not yet known. 
